Clinical Trials Directory

Trials / Unknown

UnknownNCT02346448

Endoscopic Sphincterotomy vs. Balloon Dilation for Assessment of Pancreatitis

Endoscopic Sphincterotomy vs. Balloon Dilation for Assessment of Pancreatitis: A Prospective Randomized Multicenter Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
Helios Albert-Schweitzer-Klinik Northeim · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

One of the major elements of successful endoscopic retrograde cholangiopancreatography ( ERCP) is the timely and uncomplicated cannulation of the common bile duct (CBD) . Various factors may adversely affect the cannulation procedure of the CBD leading to complications (acute pancreatitis after ERCP, perforation of the duodenum , bleeding ). Endoscopic sphincterotomy is frequently required for interventional procedures (eg stone extraction). During sphincterotomy, incision of the orifice of the papilla will be performed by using a sphincterotome. Complications due to sphincterotomy are known: Bleeding, increased rates of acute pancreatitis, small bowel perforation and scarring with consecutive stenosis of the papilla. As an alternative to sphincterotomy, balloon dilatation using balloon catheters can be performed. As a result, bleeding complications and scarring as late effects might be prevented. Current data is limited in terms of the risk of acute pancreatitis after ERCP when using a balloon catheter. This study aims to evaluate the incidence of acute pancreatitis and other complications after ERCP. Balloon dilatation of the papilla will be prospectively compared with endoscopic sphincterotomy in a randomized multicenter setting.

Conditions

Interventions

TypeNameDescription
PROCEDUREendoscopic sphincterotomysphincterotomy during ERCP
PROCEDUREballoon dilatation for 3 minutesballoon dilatation during ERCP using 10mm balloon
PROCEDUREballoon dilatation for 6 minutesballoon dilatation during ERCP using 10mm balloon

Timeline

Start date
2015-02-01
Primary completion
2019-12-01
Completion
2020-12-01
First posted
2015-01-27
Last updated
2019-02-12

Locations

3 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT02346448. Inclusion in this directory is not an endorsement.